Apolipoprotein B is an insufficient explanation for the risk of coronary disease associated with lipoprotein(a)

Cardiovasc Res. 2021 Apr 23;117(5):1245-1247. doi: 10.1093/cvr/cvab060.
No abstract available

Publication types

  • Letter
  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Apolipoprotein B-100 / blood*
  • Apolipoprotein B-100 / genetics
  • Biomarkers / blood
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / genetics
  • Female
  • Humans
  • Incidence
  • Lipoprotein(a) / blood*
  • Lipoprotein(a) / genetics
  • Male
  • Mendelian Randomization Analysis
  • Middle Aged
  • Mississippi / epidemiology
  • Risk Assessment
  • Risk Factors
  • United Kingdom / epidemiology

Substances

  • APOB protein, human
  • Apolipoprotein B-100
  • Biomarkers
  • LPA protein, human
  • Lipoprotein(a)